Suchergebnisse - (Standardsuche:ritonavir)

PubPharm (1.065)

21

Prevalence of resistance-associated substitutions to NS3, NS5A and NS5B inhibitors at DAA-failure in hepatitis C virus in Italy from 2015 to 2019

enthalten in: Le infezioni in medicina | 2021

von Rossetti, B. | Paglicci, L. | Di Maio, V. | +15

22

Effectiveness of 8- and 12-Week Treatment with Ombitasvir/ Paritaprevir/Ritonavir and Dasabuvir in Treatment-Naïve HCV Patients in a Real-Life Setting in Romania : the AMETHYST Study

enthalten in: Journal of gastrointestinal and liver diseases : JGLD | 2021

von Trifan, A. | Stanciu, C. | Iliescu, L. | +11

23

Antiviral treatment in COVID-19 : which is the most promising?-a narrative review

enthalten in: Annals of palliative medicine | 2021

von Yadav, A. | Wen, S. | Xu, X. | +1

24

Baricitinib improves respiratory function in patients treated with corticosteroids for SARS-CoV-2 pneumonia : an observational cohort study

enthalten in: Rheumatology (Oxford, England) | 2021

von Rodriguez-Garcia, J. | Sanchez-Nievas, G. | Arevalo-Serrano, J. | +3

25

Real-world efficacy and safety of Ledipasvir + Sofosbuvir and Ombitasvir/Paritaprevir/Ritonavir ± Dasabuvir combination therapies for chronic hepatitis C : A Turkish experience

enthalten in: The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology | 2020

von Değertekin, B. | Demir, M. | Akarca, U. | +47

26

Ombitasvir/paritaprevir/ritonavir and dasabuvir±ribavirin for chronic HCV infection in US veterans with psychiatric disorders

enthalten in: Journal of medical virology | 2020

von Fuchs, M. | Monto, A. | Bräu, N. | +11

27

Aspartic peptidase of Phialophora verrucosa as target of HIV peptidase inhibitors : blockage of its enzymatic activity and interference with fungal growth and macrophage interaction

enthalten in: Journal of enzyme inhibition and medicinal chemistry | 2020

von Granato, M. | Sousa, I. | Rosa, T. | +6

28

Precipitating factors causing hyperbilirubinemia during chronic hepatitis C treatment with paritaprevir/ritonavir/ombitasvir and dasabuvir

enthalten in: Journal of the Chinese Medical Association : JCMA | 2020

von Wang, Y. | Lee, W. | Wang, Y. | +4

29

Changes of inflammatory cytokines/chemokines during ravidasvir plus ritonavir-boosted danoprevir and ribavirin therapy for patients with genotype 1b hepatitis C infection

enthalten in: Journal of medical virology | 2020

von Xiao, L. | Wu, X. | Zhang, F. | +3

30

First clinical study using HCV protease inhibitor danoprevir to treat COVID-19 patients

enthalten in: Medicine | 2020

von Chen, H. | Zhang, Z. | Wang, L. | +5